Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Journal
Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
18
09
2019
accepted:
02
01
2020
entrez:
8
3
2020
pubmed:
8
3
2020
medline:
3
8
2021
Statut:
epublish
Résumé
To describe the clinical, serologic and histologic features of a cohort of patients with brachio-cervical inflammatory myopathy (BCIM) associated with systemic sclerosis (SSc) and unravel disease-specific pathophysiologic mechanisms occurring in these patients. We reviewed clinical, immunologic, muscle MRI, nailfold videocapillaroscopy, muscle biopsy, and response to treatment data from 8 patients with BCIM-SSc. We compared cytokine profiles between patients with BCIM-SSc and SSc without muscle involvement and controls. We analyzed the effect of the deregulated cytokines in vitro (fibroblasts, endothelial cells, and muscle cells) and in vivo. All patients with BCIM-SSc presented with muscle weakness involving cervical and proximal muscles of the upper limbs plus Raynaud syndrome, telangiectasia and/or sclerodactilia, hypotonia of the esophagus, and interstitial lung disease. Immunosuppressive treatment stopped the progression of the disease. Muscle biopsy showed pathologic changes including the presence of necrotic fibers, fibrosis, and reduced capillary number and size. Cytokines involved in inflammation, angiogenesis, and fibrosis were deregulated. Thrombospondin-1 (TSP-1), which participates in all these 3 processes, was upregulated in patients with BCIM-SSc. In vitro, TSP-1 and serum of patients with BCIM-SSc promoted proliferation and upregulation of collagen, fibronectin, and transforming growth factor beta in fibroblasts. TSP-1 disrupted vascular network, decreased muscle differentiation, and promoted hypotrophic myotubes. In vivo, TSP-1 increased fibrotic tissue and profibrotic macrophage infiltration in the muscle. Patients with SSc may present with a clinically and pathologically distinct myopathy. A prompt and correct diagnosis has important implications for treatment. Finally, TSP-1 may participate in the pathologic changes observed in muscle.
Identifiants
pubmed: 32144182
pii: 7/3/e694
doi: 10.1212/NXI.0000000000000694
pmc: PMC7136050
pii:
doi:
Substances chimiques
Thrombospondin 1
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Références
J Neuropathol Exp Neurol. 2010 Jun;69(6):643-53
pubmed: 20467328
Brain. 2018 Jun 1;141(6):1609-1621
pubmed: 29741608
J Clin Neuromuscul Dis. 2010 Jun;11(4):213-22
pubmed: 20516811
Am J Pathol. 2005 May;166(5):1451-63
pubmed: 15855645
Circ Res. 2007 Jul 6;101(1):88-96
pubmed: 17540977
Arthritis Rheum. 1981 May;24(5):662-8
pubmed: 7236323
Clin Rheumatol. 2005 Apr;24(2):99-102
pubmed: 15322944
Matrix Biol. 2012 Apr;31(3):178-86
pubmed: 22266026
N Engl J Med. 2015 Apr 30;372(18):1734-47
pubmed: 25923553
J Rheumatol. 2013 Sep;40(9):1545-56
pubmed: 23858045
Sci Rep. 2012;2:512
pubmed: 22803005
PLoS One. 2013;8(2):e55953
pubmed: 23405239
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Handb Clin Neurol. 2018;148:541-548
pubmed: 29478599
J Lab Clin Med. 1998 Dec;132(6):519-29
pubmed: 9851743
Ann Rheum Dis. 2009 Sep;68(9):1474-7
pubmed: 19054827
Arthritis Care Res (Hoboken). 2016 Nov;68(11):1695-1703
pubmed: 26881982
J Immunol. 1994 Nov 1;153(9):4219-29
pubmed: 7930624
Am J Pathol. 1993 Sep;143(3):678-84
pubmed: 7689791
Arch Neurol. 1992 Dec;49(12):1292-5
pubmed: 1333182
Neuromuscul Disord. 2016 Mar;26(3):240-51
pubmed: 26927626
J Rheumatol. 1983 Oct;10(5):741-7
pubmed: 6644696
Arthritis Rheum. 2013 Nov;65(11):2737-47
pubmed: 24122180
Cell Physiol Biochem. 2018;51(5):2290-2308
pubmed: 30537736
Curr Opin Rheumatol. 2016 Nov;28(6):631-5
pubmed: 27548651
Arthritis Rheum. 2006 May;54(5):1687-96
pubmed: 16646041
Muscle Nerve. 1993 Nov;16(11):1204-12
pubmed: 8413372
Cell Death Dis. 2018 Jul 10;9(7):776
pubmed: 29991677
J Rheumatol. 2009 Dec;36(12):2733-6
pubmed: 19884273
FASEB J. 2000 Jan;14(1):55-64
pubmed: 10627280
Neurol Neuroimmunol Neuroinflamm. 2017 Oct 27;5(1):e410
pubmed: 29114565
Acta Neuropathol. 1999 Dec;98(6):645-50
pubmed: 10603042
J Neuroinflammation. 2017 Nov 16;14(1):224
pubmed: 29145880
Neuropathol Appl Neurobiol. 2012 Dec;38(7):632-46
pubmed: 22989019
Acta Myol. 2015 Dec;34(2-3):95-108
pubmed: 27199536
Arch Pharm Res. 2010 Feb;33(2):275-84
pubmed: 20195829
J Neuroimmunol. 2007 Jul;187(1-2):166-74
pubmed: 17572512
J Neurol Sci. 2010 May 15;292(1-2):101-3
pubmed: 20236664
Arthritis Res Ther. 2014 May 13;16(3):R111
pubmed: 24886750
Science. 1994 Sep 9;265(5178):1582-4
pubmed: 7521539